Clinical Trial Update: Biodistribution, Dosimetry and Performance of [68Ga]Ga-DOTA-Siglec-9 in Healthy and Patients With Rheumatoid Arthritis, Vasculitis or Pulmonary Sarcoidosis [NA]

View source ↗

Summary

An ongoing clinical trial evaluating biodistribution, dosimetry, and imaging performance of Ga-68 labeled DOTA-Siglec-9 in healthy subjects and patients with rh…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pulmonary Sarcoidosis
• Rheumatoid Arthritis
• Vasculitis

Drugs mentioned

• [68Ga]Ga-DOTA-Siglec-9 (Gallium-68 labeled DOTA-Siglec-9)

Snippet

Sponsor: Turku University Hospital | Conditions: Healthy Subjects, Rheumatoid Arthritis | NA | Status: ENROLLING_BY_INVITATION